|
Volumn 296, Issue 2, 2001, Pages 537-541
|
Human CYP1B1 and anticancer agent metabolism: Mechanism for tumor-specific drug inactivation?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
CYTOCHROME P450 1B1;
DAUNORUBICIN;
DOCETAXEL;
DOXORUBICIN;
DRUG METABOLITE;
ETHOXYRESORUFIN DEETHYLASE;
ETOPOSIDE;
FLUOROURACIL;
FLUTAMIDE;
MITOXANTRONE;
PACLITAXEL;
VINBLASTINE;
VINCRISTINE;
XENOBIOTIC AGENT;
ANIMAL CELL;
ARTICLE;
BIOTRANSFORMATION;
COMPETITIVE INHIBITION;
CONTROLLED STUDY;
DRUG INACTIVATION;
ENZYME ACTIVITY;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
NONHUMAN;
PRIORITY JOURNAL;
TARGET CELL;
TUMOR;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
ARYL HYDROCARBON HYDROXYLASES;
BIOTRANSFORMATION;
CYTOCHROME P-450 CYP1A1;
CYTOCHROME P-450 ENZYME SYSTEM;
FLUTAMIDE;
HUMANS;
HYDROXYLATION;
KINETICS;
MIXED FUNCTION OXYGENASES;
NEOPLASMS;
TUMOR CELLS, CULTURED;
|
EID: 0035142865
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (183)
|
References (16)
|